I brought up this idea on WSBN discord about a week ago and I think it's starting to line up.
Just as GME was a heavily shorted stock so has been KMPH with a 71% short interest as of yesterday.
The company has a major catalyst with an FDA approved ADHD drug that is better than anything else out there on the market.
Having ADHD I have been very interested in this company.
When I spoke about this on WSBN on discord, before I was suddenly banned, there was a volume spike two minutes after. Since then some major twitter hedge fund guys have taken my idea and I wanted to get it out here.
With most of the shorting around 10.50 a share and such a big amount of the float available to short already shorted, if the stock stays above 11.00 this week you could see shorts starting to cover.
Also compared to GME, KMPH has a significantly smaller float so it could really rip in the pre or post markets without a circuit breaker kicking in it could see 60.00 a share in a GME squeeze like scenario. Also at this price KMPH could be a take out target as the last ADHD drug company that got FDA approval was swallowed up by Johnson&Johnson.
The company missed earnings, but they have the new ADHD drug, have zero debt, and have analysts rerating them to the upside.
Full disclosure I'm Long 1500 shares and I intend to ride this company to 100.00 per share or more.
Just as GME was a heavily shorted stock so has been KMPH with a 71% short interest as of yesterday.
The company has a major catalyst with an FDA approved ADHD drug that is better than anything else out there on the market.
Having ADHD I have been very interested in this company.
When I spoke about this on WSBN on discord, before I was suddenly banned, there was a volume spike two minutes after. Since then some major twitter hedge fund guys have taken my idea and I wanted to get it out here.
With most of the shorting around 10.50 a share and such a big amount of the float available to short already shorted, if the stock stays above 11.00 this week you could see shorts starting to cover.
Also compared to GME, KMPH has a significantly smaller float so it could really rip in the pre or post markets without a circuit breaker kicking in it could see 60.00 a share in a GME squeeze like scenario. Also at this price KMPH could be a take out target as the last ADHD drug company that got FDA approval was swallowed up by Johnson&Johnson.
The company missed earnings, but they have the new ADHD drug, have zero debt, and have analysts rerating them to the upside.
Full disclosure I'm Long 1500 shares and I intend to ride this company to 100.00 per share or more.
ETH - 0x7442806bA56b26000cd561E4c154CAF85de94a79